1. Food and Drug Administration. FDA grants traditional approval to tarlatamab-dlle for extensive-stage small-cell lung cancer. FDA. November 19, 2025. Accessed November 19, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback